Opinion: considerably undervalued at 6 cents
Reasons: Market cap of other MM stocks compared to MXC progress / achievements, revenue growth and market recognition via derma has been a real success - potential buyout target, the co. entering critical period post GMP for pharma - Cannepil = cash on the table, Europe market is beckoning, large and years post legalisation. The neurologist coming onto staff is critical - all signs, in spite of the scars (VC the biggest gash) and churn along the way, point firmly to u n d e r v a l u e d
- Forums
- ASX - By Stock
- RGT
- MGC - The Forgotten Updates
MGC - The Forgotten Updates, page-10
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RGT (ASX) to my watchlist
|
|||||
Last
28.5¢ |
Change
0.005(1.79%) |
Mkt cap ! $13.79M |
Open | High | Low | Value | Volume |
28.5¢ | 28.5¢ | 28.5¢ | $99 | 347 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 14314 | 28.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 14314 | 0.280 |
1 | 7100 | 0.275 |
2 | 13700 | 0.270 |
1 | 18000 | 0.265 |
1 | 2000 | 0.260 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 1000 | 1 |
0.310 | 6587 | 2 |
0.370 | 1056 | 1 |
0.380 | 1047 | 1 |
0.390 | 22620 | 2 |
Last trade - 11.04am 26/07/2024 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |